The India head & neck cancer therapeutics market is anticipated to progress with a CAGR of 9.02% over the forecasted years of 2023-2030, capturing a revenue share of $56.63 million by 2030.
In terms of revenue, the global human growth hormone market was valued at $xx million in 2022 and is expected to reach $xx million by 2032, growing at a CAGR of 8.56% during the forecast period 2023-2032.
The global vitamin D market is growing at a CAGR of 7.62% and is predicted to be $2955.84 million during the forecast year 2022 to 2032.
The Asia-Pacific vitamin D market is evaluated CAGR of 7.82% across the forecasted period of 2023 to 2032, revenue share of $839.55 million by 2032.
The Europe vitamin D market CAGR of 7.39% during the forecast years 2023 to 2032, capturing a revenue share of $763.54 million by 2032.